Predicting the clinical course of prostate cancer.
Risk stratification in prostate cancer remains a significant clinical challenge. A study in this issue of the JCI describes an exciting application of high-throughput functional genomic technology to further refine our understanding of treatment failure risk in prostate cancer patients.
McKiernan
James
J
Department of Urology, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA.
Benson
Mitchell C
MC
D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000503:physiopathology*